Autophagy as a therapy target in age-related macular degenration
Description of the granted funding
AMD is the most common cause of visual impairment in the Western world. AMD is a storage disease in which harmful protein accumulations develop behind the retina. For the first time ever, our recent study showed that AMD is associated with impaired autophagy, which is an important clean-up mechanism of the fundus of the eye. The study can be regarded as a breakthrough, as the results change our understanding of the pathogenesis of AMD and also open new avenues for the treatment of AMD. In this project, we study autophagy mechanims in AMD clinical material, animal models and stem cell cultures. We try to find novel treatments to AMD targeted to autophagy. The research project is done in University of Eastern Finland in ophthalmology group leaded by professor Kai Kaarniranta
Show moreStarting year
2020
End year
2024
Granted funding
Other information
Funding decision number
333302
Fields of science
Biomedicine
Research fields
Biolääketieteet
Identified topics
eyes, eye diseases